Your session is about to expire
← Back to Search
Probiotic
1 for MRSA Colonization (MRSA Trial)
Phase 2
Waitlist Available
Led By Dr Pierre-Jean PM Maziade, MD
Research Sponsored by Bio-K Plus International Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Summary
Trial Objectives: Primary objective: * To evaluate the efficacy of Bio-K+CL1285® in patients with Methicillin-Resistant S. aureus (MRSA) nasal colonization by comparing the MRSA decolonization following either Bio-K+CL1285® or placebo treatment. Secondary objective: * To evaluate the safety profile of Bio-K+CL1285®.
Eligible Conditions
- MRSA Colonization
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: 1Experimental Treatment1 Intervention
Bio-K+ CL1285 contains 50 billion of live bacteria
Group II: 2Placebo Group1 Intervention
placebo devoid of bacteria
Find a Location
Who is running the clinical trial?
Bio-K Plus International Inc.Lead Sponsor
7 Previous Clinical Trials
1,451 Total Patients Enrolled
Centre Hospitalier Pierre-Le GardeurUNKNOWN
Dr Pierre-Jean PM Maziade, MDPrincipal InvestigatorPierre Le Gardeur Hospital
Share this study with friends
Copy Link
Messenger